Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 553 to 556 of 556 entries
Sorted by: Best Match Show Resources per page
The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review.

Diagnostics (Basel, Switzerland)

Fujioka T, Mori M, Kubota K, Oyama J, Yamaga E, Yashima Y, Katsuta L, Nomura K, Nara M, Oda G, Nakagawa T, Kitazume Y, Tateishi U.
PMID: 33291266
Diagnostics (Basel). 2020 Dec 06;10(12). doi: 10.3390/diagnostics10121055.

Breast cancer is the most frequently diagnosed cancer in women; it poses a serious threat to women's health. Thus, early detection and proper treatment can improve patient prognosis. Breast ultrasound is one of the most commonly used modalities for...

Cite
Fujioka T, Mori M, Kubota K, et al. The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review. Diagnostics (Basel). 2020;10(12)doi: 10.3390/diagnostics10121055.
Fujioka, T., Mori, M., Kubota, K., Oyama, J., Yamaga, E., Yashima, Y., Katsuta, L., Nomura, K., Nara, M., Oda, G., Nakagawa, T., Kitazume, Y., & Tateishi, U. (2020). The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review. Diagnostics (Basel, Switzerland), 10(12), . https://doi.org/10.3390/diagnostics10121055
Fujioka, Tomoyuki, et al. "The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review." Diagnostics (Basel, Switzerland) vol. 10,12 (2020). doi: https://doi.org/10.3390/diagnostics10121055
Fujioka T, Mori M, Kubota K, Oyama J, Yamaga E, Yashima Y, Katsuta L, Nomura K, Nara M, Oda G, Nakagawa T, Kitazume Y, Tateishi U. The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review. Diagnostics (Basel). 2020 Dec 06;10(12). doi: 10.3390/diagnostics10121055. PMID: 33291266; PMCID: PMC7762151.
Copy Download .nbib Format: NLM
Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.

Annals of hematology

Hiramoto N, Yamazaki H, Nakamura Y, Uchida N, Murata M, Kondo T, Yoshioka S, Eto T, Nishikawa A, Kimura T, Ichinohe T, Atsuta Y, Onishi Y, Suzuki R, Mori T.
PMID: 34546409
Ann Hematol. 2021 Sep 21; doi: 10.1007/s00277-021-04664-z. Epub 2021 Sep 21.

Thus far, there have been no large cohort studies on total body irradiation (TBI)-containing conditioning regimens without antithymocyte globulin (ATG) in adults with aplastic anemia (AA) undergoing umbilical cord blood (UCB) transplantation (UCBT). We retrospectively analyzed 115 adults with...

Cite
Hiramoto N, Yamazaki H, Nakamura Y, et al. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Ann Hematol. 2021;doi: 10.1007/s00277-021-04664-z.
Hiramoto, N., Yamazaki, H., Nakamura, Y., Uchida, N., Murata, M., Kondo, T., Yoshioka, S., Eto, T., Nishikawa, A., Kimura, T., Ichinohe, T., Atsuta, Y., Onishi, Y., Suzuki, R., Mori, T. (2021). Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Annals of hematology, . https://doi.org/10.1007/s00277-021-04664-z
Hiramoto, Nobuhiro, et al. "Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation." Annals of hematology vol. (2021). doi: https://doi.org/10.1007/s00277-021-04664-z
Hiramoto N, Yamazaki H, Nakamura Y, Uchida N, Murata M, Kondo T, Yoshioka S, Eto T, Nishikawa A, Kimura T, Ichinohe T, Atsuta Y, Onishi Y, Suzuki R, Mori T. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Ann Hematol. 2021 Sep 21; doi: 10.1007/s00277-021-04664-z. Epub 2021 Sep 21. PMID: 34546409.
Copy Download .nbib Format: NLM
Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.

Scientific reports

Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K.
PMID: 34341466
Sci Rep. 2021 Aug 02;11(1):16042. doi: 10.1038/s41598-021-95498-2.

No abstract available.

Cite
Fukuda H, Seyama K, Ito K, et al. Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep. 2021;11(1):16042doi: 10.1038/s41598-021-95498-2.
Fukuda, H., Seyama, K., Ito, K., Ai, T., Nojiri, S., Hori, S., Wakita, M., Saito, K., Shida, Y., Nagura, R., Hasegawa, M., Kanemoto, C., Tokuhara, M., Okajima, K., Yoshikawa, Y., Katsuta, N., Yamamoto, T., Idei, M., Horiuchi, Y., Yamatani, K., Misawa, S., Naito, T., Miida, T., Sato, H., Hattori, N., Tabe, Y., & Takahashi, K. (2021). Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Scientific reports, 11(1), 16042. https://doi.org/10.1038/s41598-021-95498-2
Fukuda, Hiroshi, et al. "Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo." Scientific reports vol. 11,1 (2021): 16042. doi: https://doi.org/10.1038/s41598-021-95498-2
Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K. Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep. 2021 Aug 02;11(1):16042. doi: 10.1038/s41598-021-95498-2. PMID: 34341466; PMCID: PMC8327890.
Copy Download .nbib Format: NLM
Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.

Cancers

Fujioka Y, Sugiyama D, Matsumura I, Minami Y, Miura M, Atsuta Y, Ohtake S, Kiyoi H, Miyazaki Y, Nishikawa H, Takahashi N.
PMID: 34885012
Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235904.

Treatment-free remission (TFR) has become a therapeutic goal in chronic myeloid leukemia (CML), and approximately half of the patients with chronic phase-CML (CML-CP) with deep molecular remission (DMR) by tyrosine-kinase inhibitors (TKIs) have achieved TFR. However, the mechanism of...

Cite
Fujioka Y, Sugiyama D, Matsumura I, et al. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235904.
Fujioka, Y., Sugiyama, D., Matsumura, I., Minami, Y., Miura, M., Atsuta, Y., Ohtake, S., Kiyoi, H., Miyazaki, Y., Nishikawa, H., & Takahashi, N. (2021). Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. Cancers, 13(23), . https://doi.org/10.3390/cancers13235904
Fujioka, Yuki, et al. "Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235904
Fujioka Y, Sugiyama D, Matsumura I, Minami Y, Miura M, Atsuta Y, Ohtake S, Kiyoi H, Miyazaki Y, Nishikawa H, Takahashi N. Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. Cancers (Basel). 2021 Nov 24;13(23). doi: 10.3390/cancers13235904. PMID: 34885012; PMCID: PMC8657169.
Copy Download .nbib Format: NLM
Showing 553 to 556 of 556 entries